@TomiKilgore Had the initial pt on Marketwatch, but not the increase to 6.65 or the estimated $$ Ibio price target raised to 6.65 from 2.55 at Alliance Global Partners on 8/11
@TomiKilgore
Ben Haynor raised the firms price target to 6.65 from 2.55 and keeps a buy rating on the shares after encouraging preliminary data on one of its SARS-COV-2 vaccine candidates. https://t.co/xXGk4CJMWb
@TomiKilgore Ben Haynor raised the firms price target to 6.65 from 2.55 and keeps a buy rating on the shares after encouraging preliminary data on one of its SARS-COV-2 vaccine candidates.
https://t.co/ior7zBvV4A
@TomiKilgore Had the initial pt on Marketwatch, but not the increase to 6.65 or the estimated $$
Ibio price target raised to 6.65 from 2.55 at Alliance Global Partners on 8/11